Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues

This randomized controlled trial investigated the effectiveness of combining testosterone with a phosphodiesterase type 5 (PDE5) inhibitor to improve sexual satisfaction in women diagnosed with hypoactive sexual desire disorder (HSDD) and female sexual arousal disorder (FSAD) who exhibit low sensitivity to sexual cues. The study included 36 premenopausal women aged